running because it has 3-4 million in rebates coming after July 1st and with 5 million in the bank already the EV is 8 million while AGN which is combined with a thrombotic to work and not a unique drug like NYR was a 70 million market cap in the same position back in 2021 before GLP and before phase 1. Looking at a testing all time highs in the period ahead
running because it has 3-4 million in rebates coming after July...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
